Improving cervical cancer screening in Mexico: Results from the Morelos HPV Study
Fuente:
Redalyc
Saved in:
| Main Author: | |
|---|---|
| Format: | Artículo científico |
| Language: | en |
| Published: |
Instituto Nacional de Salud Pública
2003
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1876432502250274816 |
|---|---|
| author | Yvonne Flores |
| author_facet | Yvonne Flores |
| contents | Improving cervical cancer screening in Mexico: Results from the Morelos HPV Study Yvonne Flores Keerti Shah David Bishai Attila Lörincz Mauricio Hernández Eduardo Lazcano Jorge Salmerón Salud Pap screening HPV testing cervical cancer Objective. The purpose of this paper is to describe some ofthe results of the Morelos HPV Study. The main objective ofthe Morelos HPV Study is to evaluate the use of humanpapillomavirus (HPV) DNA testing, as compared to thePapanicolaou (Pap) test, for cervical cancer (CC) screening.Material and Methods. The Morelos HPV Study is currentlybeing conducted in Mexico, to examine the possibility of usingHPV testing for CC screening. The HPV testing of self-collectedvaginal and clinician-collected cervical specimens was evaluatedas part of this study. The acceptability of the HPV testing ofself-collected specimens was compared to that of the Pap test.A cost-effectiveness analysis (CEA) and cost-benefit analysis(CBA) was also performed. Results. The Morelos HPV Studyresults indicate that HPV testing has a greater sensitivity todetect cervical intraepithelial neoplasia (CIN) 2/3 and CC thanthe Pap test. Our results also indicate an over-all loweracceptability of the Pap test as compared to the self-collected procedure. The results of the CEA and CBA indicate thatscreening women between the ages of 20-80 for CC usingsome type of HPV testing is always more cost-effective thanscreening for CC using the Pap test. Conclusions. Our resultssuggest that self- and clinician-collected HPV testing could beused in CC prevention programs, as an effective complementor substitute for the Pap test. This paper is available too at:http://www.insp.mx/salud/index.html 2003 artículo científico 0036-3634 https://www.redalyc.org/articulo.oa?id=10609713 en http://www.redalyc.org/revista.oa?id=106 Salud Pública de México application/pdf Instituto Nacional de Salud Pública Salud Pública de México (México) Num.3 Vol.45 |
| format | Artículo científico |
| id | redalyc_10609713 |
| institution | Redalyc |
| language | en |
| publishDate | 2003 |
| publisher | Instituto Nacional de Salud Pública |
| spellingShingle | Improving cervical cancer screening in Mexico: Results from the Morelos HPV Study Yvonne Flores Salud Pap screening HPV testing cervical cancer Improving cervical cancer screening in Mexico: Results from the Morelos HPV Study Yvonne Flores Keerti Shah David Bishai Attila Lörincz Mauricio Hernández Eduardo Lazcano Jorge Salmerón Salud Pap screening HPV testing cervical cancer Objective. The purpose of this paper is to describe some ofthe results of the Morelos HPV Study. The main objective ofthe Morelos HPV Study is to evaluate the use of humanpapillomavirus (HPV) DNA testing, as compared to thePapanicolaou (Pap) test, for cervical cancer (CC) screening.Material and Methods. The Morelos HPV Study is currentlybeing conducted in Mexico, to examine the possibility of usingHPV testing for CC screening. The HPV testing of self-collectedvaginal and clinician-collected cervical specimens was evaluatedas part of this study. The acceptability of the HPV testing ofself-collected specimens was compared to that of the Pap test.A cost-effectiveness analysis (CEA) and cost-benefit analysis(CBA) was also performed. Results. The Morelos HPV Studyresults indicate that HPV testing has a greater sensitivity todetect cervical intraepithelial neoplasia (CIN) 2/3 and CC thanthe Pap test. Our results also indicate an over-all loweracceptability of the Pap test as compared to the self-collected procedure. The results of the CEA and CBA indicate thatscreening women between the ages of 20-80 for CC usingsome type of HPV testing is always more cost-effective thanscreening for CC using the Pap test. Conclusions. Our resultssuggest that self- and clinician-collected HPV testing could beused in CC prevention programs, as an effective complementor substitute for the Pap test. This paper is available too at:http://www.insp.mx/salud/index.html 2003 artículo científico 0036-3634 https://www.redalyc.org/articulo.oa?id=10609713 en http://www.redalyc.org/revista.oa?id=106 Salud Pública de México application/pdf Instituto Nacional de Salud Pública Salud Pública de México (México) Num.3 Vol.45 |
| title | Improving cervical cancer screening in Mexico: Results from the Morelos HPV Study |
| topic | Salud Pap screening HPV testing cervical cancer |
| url | https://www.redalyc.org/articulo.oa?id=10609713 |